Deutsche Bank Aktiengesellschaft »

Mineralys Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Mineralys Therapeutics

Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024Jan 2025100k200k300k5k10k15k20k25k
Value ($)Share countHistorical MLYS position of Deutsche Bank Aktiengesellschaft Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-12-31 $329k 27k 12.31
2024-09-30 $199k 17k 12.11
2024-06-30 $136k 12k 11.70
2024-03-31 $108k 8.3k 12.91
2023-09-30 $54k 5.7k 9.51
2023-06-30 $97k 5.7k 17.05
2023-03-31 $118k 7.5k 15.66

More positions owned by Deutsche Bank Aktiengesellschaft

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
UnitedHealth (UNH)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Linde SHS (LIN)
Johnson & Johnson (JNJ)

View all positions for Deutsche Bank Aktiengesellschaft

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics